Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +32.9% | +35.8% | 3 / 3 | +6.6% | +1.19 pp | +1.81 pp | +12.4% | 0.57 | 16.26 | 173 | +6,6% | 15,8 | +32,9% | 16.26 | 18.13 | −10,3% |
| Pts | 8 | 8 | 12 | 0 | 8 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 26.700 (close price on 2026-10-19)EPS (TTM): 1.642
Financial charts
1.Revenue & growth
VND bn173Q2/26
1.Revenue & growth
VND bn173Q2/26
2.Profit & growth
VND bn16,5Q2/26
3.Profit mix (Penman)
VND bn80,0Q2/26
4.Margins & cost structure
%35.4%Q2/26
5.Returns & cash cycle
% · days9.1%Q2/26
6.Earnings quality & cash
VND bn150Q2/26
7.Asset structure
VND bn1.009Q2/26
8.Funding & debt health
VND bn · times1.009Q2/26
9.Revenue backlog
VND bn50,6Q2/26
10.Valuation
times · %20,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %340Q2/26
Adjusted EPS growth, latest quarter
39.1%
Average adjusted EPS growth, 3 quarters
37.9%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26